People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Other, Software / Tech, Other Technology, Healthtech, Other Energy, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anaplan, Inc. | — | Other | Series C | $260.6M | $1.0B | 2015 |
| Looker Data Sciences, Inc. | — | Software / Tech | Series D+ | $232.4M | $3.3B | 2017 |
| AudienceScience Inc | — | Other Technology | Series B | $64.4M | $509.4M | 2013 |
| ExThera Medical Corp | — | Healthtech | Series B | $62.8M | $10.0M | 2012 |
| Financeware Holdings LLC | — | Other | Series B | $59.7M | $413.0M | 2022 |
| Kit Check, Inc. | — | Other Technology | Series B | $35.2M | $458.6M | 2016 |
| Hover Energy, LLC | — | Other Energy | Pre-Seed | $2.4M | $3.8M | 2022 |
| Northwest Analytics, Inc. | — | Other Technology | Seed | $1.4M | $46.9M | 2014 |
| Space Development Ventures, Corp. | — | Other | Pre-Seed | $230K | $5.3M | 2016 |
| Datanalytics, Inc. | — | Business Services | Pre-Seed | $160K | $5.1M | 2013 |
Robert Ward at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Ward on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rob Ward | 2 | 4 |
| Ravi Mohan | 1 | 14 |
| Walter P. Maner IV | 1 | 11 |
| Vijay Lathi | 1 | 8 |
| John Preston | 1 | 7 |
| William Ericson | 1 | 6 |
| Gentry Beach | 1 | 6 |
| John Cunningham | 1 | 6 |
| Lee Garber | 1 | 6 |
| Steve Adams | 1 | 5 |
| Christopher Griffin | 1 | 5 |
| Tomasz Tunguz | 1 | 5 |
| Adam Grossman | 1 | 5 |
| Lee P. Garber | 1 | 5 |
| James P. Ashton | 1 | 4 |
| Geoffrey Moore | 1 | 4 |
| Randall Glein | 1 | 4 |
| Randy Glein | 1 | 4 |
| Yogen Dalal | 1 | 4 |
| Sandesh Patnam | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.